Anticholinergic Premedication for Sedation With Dexmedetomidine During Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Bradycardia
Interventions
DRUG

Atropine

"To evaluate the effectiveness of atropine on prevention bradycardia,atropine 0.01\~0.03mg/kg up to 0.5mg would be injected intravenously just before starting loading dose of dexmedetomidine in group A.~During operation, heart rate decreasing 30% from initial heart rate or under 40/min would be regarded as bradycardia needing treatment, and atropine 0.5mg will be injected intravenously. This intervention would be applied to both group."

DRUG

Dexmedetomidine

Dexmedetomidine is a highly selective a2 adrenergic receptor antagonist used as sedative agent. After confirming the fixation level of spinal anesthesia, the loading dose(0.6ug/kg) of dexmedetomidine which is diluted with normal saline as 4ug/mL would be started for 10 minutes.Maintenance dose(0.25ug/kg/hr) would be continued after loading dose.

DRUG

Ephedrine

Systolic blood pressure decreasing 30% from basal blood pressure or under 90 mm Hg would be regarded as hypotension needing treatment, and ephedrine 5mg will be injected intravenously.

Trial Locations (1)

100-032

Inje University Seoul Paik Hospital, Seoul, Korea, Seoul

All Listed Sponsors
lead

Sira Bang

OTHER

NCT02522858 - Anticholinergic Premedication for Sedation With Dexmedetomidine During Spinal Anesthesia | Biotech Hunter | Biotech Hunter